Ebos Group Ltd
EBO: XNZE (NZL)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
NZD 94.50 | Prqkrc | Tvpydyhz |
Ebos Earnings: Resilient Margins but Shares Are Expensive
Narrow-moat Ebos increased first-half fiscal 2024 revenue and underlying EBITDA by 7% and 8%, respectively, driven by creditable cost control and higher-margin medical technology. Group EBITDA margin expanded slightly by 5 basis points to 4.8% despite cost pressures in labor and freight.